We are proud to announce that our user for Clarity™ Digital PCR from Taiwan has recently published a research on a diagnostic method for SMA! Read the full journal article in the link below:...

The BioPharma Expo is happening from 25th Nov 2020 – 27th Nov 2020! If you are in Japan for the BioPharma 2020 exhibition, do visit our Japan distributor – Restar Communications booth to find out more about our Clarity Plus™ Digital PCR System!...

Congratulations to Dr. Wu Xiaolin from the Singapore-MIT Alliance for Research and Technology on her latest publication on a novel Digital CRISPR-based Method for viral detection using our Clarity™ Digital PCR System! Read it at: https://www.news-medical.net/news/20201105/A-digital-CRISPR-based-method-for-quick-detection-and-absolute-quantification-of-SARS-CoV-2.aspx...

JN Medsys has received the CE mark for its ProTect COVID-19 RT-qPCR kit 2.0. The test is used for the detection of SARS-CoV-2 virus from nasopharyngeal swabs and is able to deliver results within 2 hours. Furthermore, this kit detects for multiple targets all within......

JN Medsys has received the CE mark for its ProTect COVID-19 RT-qPCR kit. The test is used for the detection of SARS-CoV-2 virus from nasopharyngeal swabs and is able to deliver results within 2 hours. The test has also received Singapore Health Sciences Authority provisional......

Complementary solutions to boost global COVID-19 testing capabilities Singapore, 14 April 2020 – Two Singapore firms, Camtech Diagnostics Pte. Ltd. (“Camtech Diagnostics”) and JN Medsys Pte. Ltd. (“JN Medsys”), have obtained provisional authorisation from the Health Sciences Authority (“HSA”), the Singapore authority regulating health products,......

JN Medsys announces today that its ProTect Covid-19 kit has received provisional authorisation from Singapore’s Health Sciences Authority (HSA) for in-vitro diagnostic use. The ProTect kit is a nucleic acid test that detects for the virus that causes COVID-19. It identifies the genetic material of......